StockNews.AI
TRNS
StockNews.AI
90 days

Transcat to Participate in the 22nd Annual Craig-Hallum Institutional Investor Conference

1. Transcat will attend the Craig-Hallum Institutional Investor Conference on May 28, 2025. 2. Key executives will hold one-on-one meetings with investors during the conference. 3. The company aims to leverage its brand for organic sales growth. 4. Transcat excels in calibration services for regulated industries like life sciences. 5. They plan to expand their calibration market via acquisitions and investments.

5m saved
Insight
Article

FAQ

Why Bullish?

The investor conference will increase visibility among potential investors, historically supporting stock prices.

How important is it?

The article mentions a key corporate event potentially attracting investor interest and boosting confidence.

Why Short Term?

Shareholder sentiment may improve shortly after the conference due to investor engagement.

Related Companies

ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration services, cost control and optimization services, and distribution and rental of value-added professional grade handheld test, measurement, and control instrumentation, will participate in the 22nd Annual Craig-Hallum Institutional Investor Conference being held on May 28, 2025, at the Depot Renaissance Hotel in Minneapolis, Minnesota.

Transcat Chief Executive Officer Lee Rudow, Chief Financial Officer Tom Barbato, and Chief Operating Officer Mike West will conduct in-person one-on-one and small group meetings throughout the conference.

22nd Annual Craig-Hallum Institutional Investor Conference
Date: May 28, 2025
Location: Depot Renaissance Hotel in Minneapolis, Minnesota
Format: In-person 1x1 and small group meetings
Conference Website: Click here

For more information on the conference, or to schedule a one-on-one meeting with Transcat management, please contact your Craig-Hallum representative or you may also email your request to TRNS@mzgroup.us or call Chris Tyson at (949) 491-8235.

About Transcat

Transcat, Inc. is a leading provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly the Life Science industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. Transcat provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its 33 Calibration Service Centers strategically located across the United States, Puerto Rico, Canada, and Ireland. Inclusive of customer embedded locations and other field offices, we operate out of more than 50 locations. The breadth and depth of measurement parameters addressed by Transcat’s ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry.

Transcat also operates as a leading value-added distributor that markets, sells, and rents new and used national and proprietary brand instruments to customers primarily in North America. The Company believes its combined Service and Distribution segment offerings, experience, technical expertise, and integrity create a unique and compelling value proposition for its customers.

Transcat’s strategy is to leverage its strong brand and unique value proposition that includes its comprehensive instrument service capabilities, enterprise asset management, and leading distribution platform to drive organic sales growth. The Company will also look to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model. More information about Transcat can be found at: Transcat.com.

Related News